• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Selective β1 Blocker
    3 Drugs classified under this drug class

    All the Drug Class Drugs

    Lopresor Divitabs
    full basket chart
    Lopresor Divitabs

    Selective β1 Blocker. Metoprolol Tartrate 200 mg.
    DIVITABS (fractional S.R.): 14 (calendar
    pack). 1/2-1 tab. in morn.
    Hypertens., ang. pect., arrhythm., proph.
    myocard. reinfarct., proph. migraine.

    full basket chart

    Selective β1 Blocker. Metoprolol Tartrate 100 mg.
    TABS: 30. Hypertens: 100 mg dly.
    maint: 100-200 mg dly. See lit. Ang.
    pect: 100-150 mg dly. in 2-3 div. doses.
    See lit.
    Hypertens., ang. pect., proph. myocard.
    reinfarct., reduce CV mort. in
    hemodynam. pts. with acute M.I., proph.
    migraine syndr., proph. of paroxys.
    tachycard., prior to card. catheterisation.
    C/I: Bradycard., Adams-Stokes attacks.

    full basket chart

    Selective β1 Blocker. Atenolol 25, 50, 100 mg.
    TABS.: 30 x 25mg, 50mg, 100mg.
    The dose must always be adjust. individ. with the lowest possible init. dosage.
    Ang.: initial. 50mg ×1/d, the dosage being incr. gradual. to 100mg after 1 wk., as needed and tolerated.
    M.I.: For pts. who present some days after suffer. an acute MI, 100 mg dly. is recomm. for long-term prophylaxis of MI.
    Hypertens.: initial. 25-50 mg ×1/d, the dosage being incr.  gradual. to
    100 mg ×1/d after 2 wks. as needed and tolerated.
    Elderly: dosage requirem. may be reduced especial.  in pts. with impair. renal funct.  See lit.
    Child: Due to the lack of experience in ped. pts.- not recommended

    Renal failure: See Lit.
    Tmt.  of Ang. pect.; Acute M.I.; Hypertens. C/I: Pts. with: known hypersens. to act. substan., cardiogenic shock., uncontrol.  HF.,
    sick sinus syndr., 2nd or 3rd degree heart block., untreated phaeochromocytoma.,
    metabolic acidosis., bradycard. (<45 bpm)., hypotens., Severe peripher.  arterial circulat.  disturban. See lit.